Erratum to: SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost, Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter, Phase III Clinical Trial

Erratum to: SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost, Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter, Phase III Clinical Trial

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical infectious diseases 2020-05, Vol.70 (11), p.2459-2459
1. Verfasser: Merat, Shahin
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2459
container_issue 11
container_start_page 2459
container_title Clinical infectious diseases
container_volume 70
creator Merat, Shahin
description
doi_str_mv 10.1093/cid/ciz931
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2305034350</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/cid/ciz931</oup_id><sourcerecordid>2305034350</sourcerecordid><originalsourceid>FETCH-LOGICAL-c191t-1631c310aa643029e0f384f73c9170a7c0ff6c0a14dd1c02d8459c3f552c91b43</originalsourceid><addsrcrecordid>eNp9kctu1DAUhiMEomVgwwOgs0FCKIFz4iSTzK5KLzPSIKrOFJaR4zgdo4wdbKelPDWPgMsUlix8-aVPn87RH0WvCT8QVuyjUF04PytGT6Jjytk8KfKKnoY_5mWSlaw8il449w2RqMT8eXTEqMC8wPI4-nVmLffTHrxZwOaUEHEBS3Wzg83kPFdadvBFWT7AlXSj0U7CFfcSlAZiBcEl90pq7-Cr8jtYyjFkrxzUcCG18fejdEAxpDGwGLjuIINrp_QNcFibu0QY52M4Vz9kl3QmyGuzb5UOEqNhy9tBejD9g0taJWBjeuPa6VbZP65TLgbuuQt5ASfwaRq8EmEaaWO43PGgW61WUA9KKxE22FrFh5fRs54PTr56fGfR9fnZtl4m688Xq_pknQiqyCdUMBKMkPMiY5hWEntWZv2ciYrmyOcC-74QyCnrOhKYdmWWV4L1eZ4Gos3YLHp38I7WfJ-k881eOSGHgWtpJtekDHNkGQvXLHp_QIU1zlnZN6NVe27vG8LmoeEmNNwcGg7wm0fv1O5l9w_9W2kA3h4AM43_E_0GSFGs_Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2305034350</pqid></control><display><type>article</type><title>Erratum to: SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost, Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter, Phase III Clinical Trial</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><creator>Merat, Shahin</creator><creatorcontrib>Merat, Shahin ; SD1000 Research Team</creatorcontrib><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1093/cid/ciz931</identifier><identifier>PMID: 31605608</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><ispartof>Clinical infectious diseases, 2020-05, Vol.70 (11), p.2459-2459</ispartof><rights>The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2019</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1578,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31605608$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Merat, Shahin</creatorcontrib><creatorcontrib>SD1000 Research Team</creatorcontrib><title>Erratum to: SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost, Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter, Phase III Clinical Trial</title><title>Clinical infectious diseases</title><addtitle>Clin Infect Dis</addtitle><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kctu1DAUhiMEomVgwwOgs0FCKIFz4iSTzK5KLzPSIKrOFJaR4zgdo4wdbKelPDWPgMsUlix8-aVPn87RH0WvCT8QVuyjUF04PytGT6Jjytk8KfKKnoY_5mWSlaw8il449w2RqMT8eXTEqMC8wPI4-nVmLffTHrxZwOaUEHEBS3Wzg83kPFdadvBFWT7AlXSj0U7CFfcSlAZiBcEl90pq7-Cr8jtYyjFkrxzUcCG18fejdEAxpDGwGLjuIINrp_QNcFibu0QY52M4Vz9kl3QmyGuzb5UOEqNhy9tBejD9g0taJWBjeuPa6VbZP65TLgbuuQt5ASfwaRq8EmEaaWO43PGgW61WUA9KKxE22FrFh5fRs54PTr56fGfR9fnZtl4m688Xq_pknQiqyCdUMBKMkPMiY5hWEntWZv2ciYrmyOcC-74QyCnrOhKYdmWWV4L1eZ4Gos3YLHp38I7WfJ-k881eOSGHgWtpJtekDHNkGQvXLHp_QIU1zlnZN6NVe27vG8LmoeEmNNwcGg7wm0fv1O5l9w_9W2kA3h4AM43_E_0GSFGs_Q</recordid><startdate>20200523</startdate><enddate>20200523</enddate><creator>Merat, Shahin</creator><general>Oxford University Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20200523</creationdate><title>Erratum to: SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost, Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter, Phase III Clinical Trial</title><author>Merat, Shahin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c191t-1631c310aa643029e0f384f73c9170a7c0ff6c0a14dd1c02d8459c3f552c91b43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Merat, Shahin</creatorcontrib><creatorcontrib>SD1000 Research Team</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Merat, Shahin</au><aucorp>SD1000 Research Team</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Erratum to: SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost, Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter, Phase III Clinical Trial</atitle><jtitle>Clinical infectious diseases</jtitle><addtitle>Clin Infect Dis</addtitle><date>2020-05-23</date><risdate>2020</risdate><volume>70</volume><issue>11</issue><spage>2459</spage><epage>2459</epage><pages>2459-2459</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><cop>US</cop><pub>Oxford University Press</pub><pmid>31605608</pmid><doi>10.1093/cid/ciz931</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1058-4838
ispartof Clinical infectious diseases, 2020-05, Vol.70 (11), p.2459-2459
issn 1058-4838
1537-6591
language eng
recordid cdi_proquest_miscellaneous_2305034350
source Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection; EZB Electronic Journals Library
title Erratum to: SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost, Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter, Phase III Clinical Trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T21%3A23%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Erratum%20to:%20SD1000:%20High%20Sustained%20Viral%20Response%20Rate%20in%201361%20Patients%20With%20Hepatitis%20C%20Genotypes%201,%202,%203,%20and%204%20Using%20a%20Low-cost,%20Fixed-dose%20Combination%20Tablet%20of%20Generic%20Sofosbuvir%20and%20Daclatasvir:%20A%20Multicenter,%20Phase%20III%20Clinical%20Trial&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Merat,%20Shahin&rft.aucorp=SD1000%20Research%20Team&rft.date=2020-05-23&rft.volume=70&rft.issue=11&rft.spage=2459&rft.epage=2459&rft.pages=2459-2459&rft.issn=1058-4838&rft.eissn=1537-6591&rft_id=info:doi/10.1093/cid/ciz931&rft_dat=%3Cproquest_cross%3E2305034350%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2305034350&rft_id=info:pmid/31605608&rft_oup_id=10.1093/cid/ciz931&rfr_iscdi=true